What Is Parkinson's Disease?

Parkinson's disease is a progressive neurodegenerative disorder that primarily affects the dopamine-producing neurons in a region of the brain called the substantia nigra. As these neurons deteriorate and die, the loss of dopamine leads to increasingly impaired movement control. Parkinson's affects approximately one million Americans, and it is the second most common neurodegenerative disease after Alzheimer's.

The hallmark motor symptoms of Parkinson's include tremor (rhythmic shaking, typically of the hands or limbs at rest), rigidity (stiffness of the limbs and trunk), bradykinesia (slowness of movement), and postural instability (impaired balance and coordination). Non-motor symptoms — including cognitive changes, depression, sleep disturbances, autonomic dysfunction, and fatigue — can be equally or more disabling than the motor symptoms for many patients.

Parkinson's is typically staged using the Hoehn and Yahr scale (stages 1 through 5, where 5 is complete dependency) or the more detailed Unified Parkinson's Disease Rating Scale (UPDRS). While these staging systems are useful clinically, the SSA focuses on documented functional limitations rather than a staging score alone.

Blue Book Listing 11.06: Parkinson's Disease

The SSA evaluates Parkinson's disease under Blue Book Section 11.06 (Parkinsonian syndrome). To meet this listing, your medical records must show significant limitations in motor function with at least one of the following:

Key Insight: Meeting listing 11.06 typically requires moderate to advanced Parkinson's. However, the SSA must evaluate ALL your limitations — including cognitive changes, depression, and medication "off" periods — not just the motor symptoms observed during a brief examination. Many patients function significantly worse during medication "off" periods.

Even patients who do not formally meet listing 11.06 can often win SSDI benefits through a Residual Functional Capacity assessment, particularly those over age 50 where the Medical-Vocational Guidelines (Grid Rules) may favor a disability finding even with a reduced RFC.

Evidence the SSA Needs for Parkinson's Claims

Neurologist Diagnosis and Treatment Records

A confirmed diagnosis from a movement disorder specialist or neurologist is essential. Records should document all four cardinal motor features (tremor, rigidity, bradykinesia, and postural instability), UPDRS or functional scores, response to levodopa, and the progression of symptoms over time. Movement disorder specialists carry particular credibility with SSA adjudicators.

DaTscan (Dopamine Transporter Scan)

A DaTscan is a nuclear imaging technique that can demonstrate loss of dopaminergic neurons in the striatum, providing objective evidence consistent with Parkinson's disease. While not required for the diagnosis, including DaTscan results (when available) adds significant objective support to your claim.

Medication History and On/Off Periods

Documentation of levodopa (Sinemet) and other antiparkinsonian medications — including dosage, schedules, and how symptoms respond — is important. Crucially, your records should reflect "off" period symptoms: the predictable worsening that occurs when medication levels drop between doses. Many patients experience dramatic functional decline during off periods that would render them unable to work reliably.

Functional and Cognitive Assessments

Physical therapy evaluations documenting gait, balance, and fall history, occupational therapy assessments of fine motor ability, and cognitive testing (for Parkinson's disease dementia or mild cognitive impairment) all strengthen the RFC picture. Fall history is particularly important — repeated falls severely limit what work environments a person can safely navigate.

RFC Considerations for Parkinson's Disease

The RFC for Parkinson's patients typically addresses:

Frequently Asked Questions

No. Parkinson's disease does not automatically qualify you for SSDI. The SSA evaluates the specific functional limitations caused by your Parkinson's under Blue Book listing 11.06 or through an RFC assessment. Early-stage Parkinson's with mild symptoms may not meet the listing criteria, while advanced Parkinson's with severe motor dysfunction typically will. The key is documenting how your specific symptoms — tremor, rigidity, bradykinesia, postural instability, and any cognitive changes — limit your ability to perform work-related activities on a sustained basis.
There is no single Hoehn and Yahr stage at which SSDI is guaranteed, but the SSA's Blue Book listing 11.06 generally aligns with moderate to advanced Parkinson's — roughly stages 3 to 5 on the Hoehn and Yahr scale. Stage 3 involves bilateral involvement and balance impairment; stages 4 and 5 involve severe disability or full dependency. However, even stage 2 Parkinson's may qualify through RFC if your tremor, rigidity, or medication side effects prevent you from performing your past work or any other work that exists in significant numbers in the national economy.
It is more difficult — but not impossible — to qualify for SSDI early in a Parkinson's diagnosis. Early-stage disease with mild symptoms rarely meets the Blue Book listing criteria. However, if your occupation requires fine motor skills, steady hands, or precise movement (such as surgery, electrical work, or skilled manufacturing), even early Parkinson's symptoms may prevent you from performing your past relevant work. An RFC assessment focused on the demands of your specific occupation can sometimes support a successful early-stage claim, particularly for applicants over 50 where the Medical-Vocational Guidelines may favor a disability finding.